RESEARCH TRIANGLE PARK, N.C., Oct. 19, 2009 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that data related to its collaboration with Pfizer focused on certain sodium channels for the treatment of pain and related conditions were presented in two poster presentations at the Neuroscience 2009 Annual Meeting sponsored by the Society for Neuroscience (“SFN”) in Chicago, Illinois.
